학술논문
Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Counts (50 – 100 × 109/L): Final Analysis of an Open-Label Phase 2 Study
Document Type
Article
Author
Source
In Clinical Lymphoma, Myeloma and Leukemia May 2022 22(5):336-346
Subject
Language
ISSN
2152-2650